• Lonza Expands Capsule Manufacturing Capacity americanpharmaceuticalreview
    October 29, 2020
    Lonza announced a CHF85m ($93m) investment in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry.
PharmaSources Customer Service